NEW YORK (GenomeWeb) – GenDx announced that it has received Canadian ISO certification, enabling the firm to start the registration procedure for its Sanger and next-generation sequencing HLA reagents and software for diagnostic purposes in Canada.

Specifically, the Dutch molecular diagnostics firm said it received CAN/CSA ISO 13485:2003 certification, a standard that forms the basis for the Canadian Medical Devices Conformity Assessment System. The system was created by Health Canada and the Standards Council to implement Canada's medical devices regulations, Gendx noted.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.

Sponsored by
Thermo Fisher Scientific

In this webinar, the first in the “New Frontiers in Liquid Biopsy Research” series, Bea Bellosillo, head of pathology at the Hospital del Mar, will discuss her experience evaluating an early-access lung cancer panel that detects copy number variants and fusions.